Publications - 'P'

Publications 2201 - 2225 de 2458
| % | ( | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | < | ? | A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | [ | ` | {
Titre DOI
Prospective Evaluation of Serum beta-Glucan Testing in Patients With Probable or Proven Fungal Diseases
C. Angebault; F. Lanternier; F. Dalle; C. Schrimpf; A.L. Roupie; A. Dupuis; A. Scemla; E. Paubelle; D. Caillot; B. Neven; P. Frange; F. Suarez; C. D'Enfert; O. Lortholary; M.E. Bougnoux
2016 		10.1093/ofid/ofw128
Prospective Evaluation of the First Option, Second-Line Therapy in Childhood Chronic Immune Thrombocytopenia: Splenectomy or Immunomodulation
S. Ducassou; H. Fernandes; H. Savel; Y. Bertrand; T. Leblanc; W.Abou Chahla; M. Pasquet; G. Leverger; V. Barlogis; C. Thomas; S. Bayart; I. Pellier; C. Armari-Alla; C. Guitton; N. Cheikh; D. Kherfellah; G. Vassal; R. Thiebaut; S. Laghouati; N. Aladjidi
2021 		10.1016/j.jpeds.2020.12.018
Prospective evaluation of the reliability of the combined use of two models to predict non-sentinel lymph node status in breast cancer patients with metastatic sentinel lymph nodes: The MSKCC nomogram and the Tenon score - PHRC-NOTEGS study
R. Rouzier; C. Uzan; A. Rousseau; E. Guillot; S. Zilberman; C. Meyer; P. Estevez; P.F. Dupre; D. Kere; V. Doridot; G. D'halluin; X. Fritel; N. Pouget; C. Mazouni; T. Simon; C. Coutant
2015
Prospective interest in deploying multi-omics approaches to solve unsolved patients with suspected monogenic developmental delay syndromes
Y. Duffourd; E. Tisserant; A. Plagos; P. Callier; M. Tran-Them; A. Bruel; A. Denomme-Pichon; C. Philippe; B. Isidor; S. Heide; A. Afenjar; D. Rodriguez; C. Mignot; D. Heron; M. Vincent; P. Charles; S. Moutton; N. Jean; S. Odent; C. Dubourg; A. Faudet; B. Keren; B. Cogne; A. Boland; R. Olaso; C. Thauvin; L. Faivre; J. Deleuze; A. Vitobello
2019
Prospective interest in deploying multi-omics approaches to solve unsolved patients with suspected monogenic developmental delay syndromes
Y. Duffourd; E. Tisserant; A. Plagos; P. Callier; M. Tran-Them; A. Bruel; A. Denomme-Pichon; C. Philippe; B. Isidor; S. Heide; A. Afenjar; D. Rodriguez; C. Mignot; D. Heron; M. Vincent; P. Charles; S. Moutton; N. Jean; S. Odent; C. Dubourg; A. Faudet; B. Keren; B. Cogne; A. Boland; R. Olaso; C. Thauvin; L. Faivre; J. Deleuze; A. Vitobello
2019
Prospective observational study of portal-hypertensive bleeding in 914 cirrhotic patients in France (CHOC study) : high proportion of high-risk patients but limited access to TIPS
D. Thabut; A.Jean Remy; N. Carbonell; X. Causse; J. Coelho; J.Francois D. Cadranel; J.Paul Cervoni; S. Bramli; I. Archambeaud; P. Ah-Soune; F. Ehrhard; A. Pariente; C. Bureau; J.P. Dupuychaffray; F. Rostain; F. Skinazi; J. Vergniol; R. Vitte; A.L. Pelletier; J. Henrion; A. Guillygomarc'h; S. Combet; A. Pauwels
2014
Prospective observational study on pazopanib in patients treated for advanced/metastatic renal cell carcinoma (RCC): APOLON Study
P. Barthelemy; L. Albiges; B. Escudier; T. Lebret; P. Bigot; U. Stein; L.M. Dourthe; J. De La Cruz; M. Tindel; A. Thiery-Vuillemin
2020
Prospective observational study on pazopanib in patients treated for advanced/metastatic renal cell carcinoma (RCC): APOLON Study
P. Barthelemy; L. Albiges; B. Escudier; T. Lebret; P. Bigot; U. Stein; L.M. Dourthe; J. De La Cruz; M. Tindel; A. Thiery-Vuillemin
2020
PROSPECTIVE PHASE II TRIAL OF LENALIDOMIDE IN ASSOCIATION WITH CHOP IN ELDERLY PATIENTS WITH ANGIOIMMUNOBLASTIC T CELL LYMPHOMA (AITL): INTERIM ANALYSIS OF A LYSA STUDY
V. Safar; L. De Leval; M. Meignan; E. Bachy; G. Cartron; M.P. Moles-Moreau; A. Delmer; R. Bouabdallah; L. Voillat; B. Corront; O. Casasnovas; V. Cacheux; R. Gressin; Y. Robreau; S. Pallardy; H. Tilly; M.N. Delfau-Larue; P. Gaulard; C. Haioun
2015
Prospective pilot study of CT-guided microwave ablation in the treatment of osteoid osteomas
C. Prud'homme; J.P. Nueffer; M. Runge; J. Dubut; B. Kastler; S. Aubry
2017 		10.1007/s00256-016-2558-5
Prospective pooled analysis of six phase III trials investigating duration of adjuvant (adjuv) oxaliplatin-based therapy (3 vs 6 months) for patients (pts) with stage III colon cancer (CC): The IDEA (International Duration Evaluation of Adjuvant chemother
Q. Shi; A.F. Sobrero; A.Frank Shields; T. Yoshino; J. Paul; J. Taieb; I. Sougklakos; R. Kerr; R. Labianca; J.A. Meyerhardt; F. Bonnetain; T. Watanabe; I. Boukovinas; L.A. Renfro; A. Grothey; D. Niedzwiecki; V. Torri; T. Andre; D.J. Sargent; T. Iveson
2017 		10.1200/JCO.2017.35.18_suppl.LBA1
Prospective pooled analysis of six phase III trials investigating duration of adjuvant (adjuv) oxaliplatin-based therapy (3 vs 6 months) for patients (pts) with stage III colon cancer (CC): The IDEA (International Duration Evaluation of Adjuvant chemother
Q. Shi; A.F. Sobrero; A.Frank Shields; T. Yoshino; J. Paul; J. Taieb; I. Sougklakos; R. Kerr; R. Labianca; J.A. Meyerhardt; F. Bonnetain; T. Watanabe; I. Boukovinas; L.A. Renfro; A. Grothey; D. Niedzwiecki; V. Torri; T. Andre; D.J. Sargent; T. Iveson
2017 		10.1200/JCO.2017.35.15_suppl.LBA1
Prospective pooled analysis of six phase III trials investigating duration of adjuvant (adjuv) oxaliplatin-based therapy (3 vs 6 months) for patients (pts) with stage III colon cancer (CC): Updated results of IDEA (International Duration Evaluation of Adj
A. Grothey; A. Sobrero; J.A. Meyerhardt; T. Yoshino; J. Paul; J. Taieb; I. Souglakos; R. Kerr; R. Labianca; A.F. Shields; F. Bonnetain; T. Yamanaka; I. Boukovinas; Q. Shi; J.P. Meyers; D. Niedzwiecki; V. Torri; D.J. Sargent; T. Andre; T. Iveson
2017
Prospective precision medicine trial of crizotinib (C) in patients (pts) with advanced, inoperable inflammatory myofibroblastic tumor (IMFT) with and without ALK alterations: EORTC phase II study 90101 ``CREATE''
P. Schoffski; J. Sufliarsky; H. Gelderblom; J.Y. Blay; S.J. Strauss; S. Stacchiotti; P. Rutkowski; L.H. Lindner; M.G. Leahy; A. Italiano; N. Isambert; M. Debiec-Rychter; R. Sciot; T. Van Cann; S. Marreaud; A. Nzokirantevye; S. Collette; A. Wozniak
2018 		10.1158/1538-7445.AM2018-CT045
Prospective randomized double blind CRAPO study comparing the Ropivacaine 10 mg/mL alone with the association Ropivacaine 10 mg/mL and Clonidine 1 mu g/kg in peribulbar anesthesia for surgery of the posterior segment of the eye
G. Bertrand
2014 		10.1016/j.annfar.2014.07.483
Prospective randomized study of sexual function in men taking dutasteride for the treatment of androgenetic alopecia
T.F. Tsai; G.Seong Choi; B.Joon Kim; M.B. Kim; C.Fai Ng; P. Kochhar; S. Jasper; B. Brotherton; B. Orban; Z. Lulic
2018 		10.1111/1346-8138.14329
PROSPECTIVE STUDY OF SPLENECTOMY IN AUTO-IMMUNE CYTOPENIA OF CHILDREN
N. Aladjidi; Y. Bertrand; H. Fernandes; B. Nelken; M. Pasquet; N. Cheikh; S. Bayart; C. Armari-Alla; H. Chambost; Y. Perel; T. Leblanc; G. Leverger
2016
PROSPECTIVE STUDY OF SPLENECTOMY IN AUTO-IMMUNE CYTOPENIA OF CHILDREN
N. Aladjidi; Y. Bertrand; H. Fernandes; B. Nelken; M. Pasquet; N. Cheikh; S. Bayart; C. Armari-Alla; H. Chambost; Y. Perel; T. Leblanc; G. Leverger
2016
Prospective study of tendon healing and functional gain after arthroscopic repair of isolated supraspinatus tear
N. Bagheri; N. Bonnevialle; D. Gallinet; J. Barth; L. Labattut; P. Metais; A. Godeneche; J. Garret; P. Clavert; I. Fatras-Meyer; P. Collin; F.Arthroscop Soc
2020 		10.1016/j.otsr.2020.08.007
Prospective Study of the Evolution of Blood Lymphoid Immune Parameters during Dacarbazine Chemotherapy in Metastatic and Locally Advanced Melanoma Patients
G. Mignot; A. Hervieu; P. Vabres; S. Dalac; G. Jeudy; B. Bel; L. Apetoh; F. Ghiringhelli
2014 		10.1371/journal.pone.0105907
Prospective validation of a lymphocyte infiltration prognostic test in stage III colon cancer patients treated with adjuvant FOLFOX
J.F. Emile; C. Julie; K. Le Malicot; C. Lepage; J. Tabernero; E. Mini; G. Folprecht; J.L. Van Laethem; S. Dimet; C. Boulagnon-Rombi; M.A. Allard; F. Penault-Llorca; J. Bennouna; P. Laurent-Puig; J. Taieb; P.E.T.A.C.C.8Study Investigators
2017 		10.1016/j.ejca.2017.04.025
Prospective validation of the PML risk biomarker L-selectin and influence of natalizumab extended intervals
N. Schwab; T. Schneider-Hohendorf; B. Pignolet; F. Bucciarelli; L. Scandella; J. Ciron; D. Biotti; C. Lebrun-Frenay; G. Mathey; P. Clavelou; J. Pelletier; P. Ostkamp; I. Meinl; S. Windhagen; L. Klotz; C.C. Gross; S.G. Meuth; F. Deisenhammer; D. Brassat; H. Wiendl; M. Martinez; O. Heinzlef; H. Zephir; O. Anne; B. Audoin; C. Bensa; E. Berger; P. Cabre; G. Castelnovo; N. Collongues; M. Coustans; A. Creange; D. Dive; G. Edan; A. Fromont; O. Gout; R. Gouider; J. Grimaud; P. Hautecoeur; A. Kiatkoswki; E. LePage; R. Marignier; T. Moreau; J.C. Ouallet; C. Papeix; L. Rumbach; P. Seeldrayers; I.Slassi Sennou; B. Stankoff; A. Tourbah; E. Thouvenot; P. Vermersch; B.M.S.Study Grp
2019 		10.1212/WNL.0000000000008135
Prospective, randomized, controlled trial of polymer cable ties versus standard wire closure of midline sternotomy
S.F. Marasco; L. Fuller; A. Zimmet; D. McGiffin; M. Seitz; S. Ch'ng; S. Gangahanumaiah; M. Bailey
2018 		10.1016/j.jtcvs.2018.04.025
Prospective, Randomized, Multicenter, Phase III Study of Fluorouracil, Leucovorin, and Irinotecan Versus Epirubicin, Cisplatin, and Capecitabine in Advanced Gastric Adenocarcinoma: A French Intergroup (Federation Francophone de Cancerologie Digestive, Fed
R. Guimbaud; C. Louvet; P. Ries; M. Ychou; E. Maillard; T. Andre; J.M. Gornet; T. Aparicio; S. Nguyen; A. Azzedine; P.L. Etienne; E. Boucher; C. Rebischung; P. Hammel; P. Rougier; L. Bedenne; O. Bouche
2014 		10.1200/JCO.2013.54.1011
Prospects and applications of photonic neural networks
C. Huang; V.J. Sorger; M. Miscuglio; M. Al-Qadasi; A. Mukherjee; L. Lampe; M. Nichols; A.N. Tait; T.Ferreira de Lima; B.A. Marquez; J. Wang; L. Chrostowski; M.P. Fok; D. Brunner; S. Fan; S. Shekhar; P.R. Prucnal; B.J. Shastri
2022 		10.1080/23746149.2021.1981155

Pages